Press "Enter" to skip to content

1.8 billion doses of new vaccine deal from EU: 10 doses drop per person – health news


The European Union (EU) has approved the contract that will provide a total of 1.8 billion doses, 900 million of which are optional, from the vaccine developed by BioNTech-Pfizer against the new type of corona virus (Covid-19).

EU Commission President Ursula von der Leyen announced on his social media account that a new contract has been signed with BioNTech-Pfizer for the purchase of Covid-19 vaccine.

Pointing out that the vaccination process is progressing well in Europe, Von der Leyen stated that additional doses will be used in immunity-boosting vaccines, in the fight against emerging new variants, and in vaccination of children and young people.

Von der Leyen noted that the EU Commission has approved a purchase agreement with BioNTech-Pfizer for the years 2021-2023 for a total of 1.8 billion doses of which 900 million doses are optional.

According to the German news agency, the EU will pay $ 43 billion for this contract.

The EU has so far, including options, to receive 2.4 billion doses with BioNTech-Pfizer, 400 million with AstraZeneca, 300 million with Sanofi-GSK, 400 million with Johnson & Johnson, 405 million with CureVac, 460 million with Moderna. has a contract.

Until now, vaccines produced by BioNTech-Pfizer, Moderna, AstraZeneca and Johnson & Johnson companies have received EU approval.

Considering these conventions, the EU administration aims to vaccinate 70 percent of the adult population in the EU, which has a population of 450 million during the summer months.


Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *